1. Home
  2. TRVI vs ASTL Comparison

TRVI vs ASTL Comparison

Compare TRVI & ASTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • ASTL
  • Stock Information
  • Founded
  • TRVI 2011
  • ASTL 1902
  • Country
  • TRVI United States
  • ASTL Canada
  • Employees
  • TRVI N/A
  • ASTL N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • ASTL Steel/Iron Ore
  • Sector
  • TRVI Health Care
  • ASTL Industrials
  • Exchange
  • TRVI Nasdaq
  • ASTL Nasdaq
  • Market Cap
  • TRVI 725.7M
  • ASTL 733.5M
  • IPO Year
  • TRVI 2019
  • ASTL N/A
  • Fundamental
  • Price
  • TRVI $6.89
  • ASTL $6.63
  • Analyst Decision
  • TRVI Strong Buy
  • ASTL
  • Analyst Count
  • TRVI 9
  • ASTL 0
  • Target Price
  • TRVI $19.94
  • ASTL N/A
  • AVG Volume (30 Days)
  • TRVI 1.6M
  • ASTL 944.0K
  • Earning Date
  • TRVI 08-07-2025
  • ASTL 07-22-2025
  • Dividend Yield
  • TRVI N/A
  • ASTL 2.94%
  • EPS Growth
  • TRVI N/A
  • ASTL N/A
  • EPS
  • TRVI N/A
  • ASTL N/A
  • Revenue
  • TRVI N/A
  • ASTL $1,635,857,227.00
  • Revenue This Year
  • TRVI N/A
  • ASTL $0.95
  • Revenue Next Year
  • TRVI N/A
  • ASTL $21.63
  • P/E Ratio
  • TRVI N/A
  • ASTL N/A
  • Revenue Growth
  • TRVI N/A
  • ASTL N/A
  • 52 Week Low
  • TRVI $2.36
  • ASTL $4.17
  • 52 Week High
  • TRVI $7.48
  • ASTL $12.14
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 64.54
  • ASTL 51.03
  • Support Level
  • TRVI $5.41
  • ASTL $6.88
  • Resistance Level
  • TRVI $6.08
  • ASTL $7.14
  • Average True Range (ATR)
  • TRVI 0.32
  • ASTL 0.27
  • MACD
  • TRVI 0.14
  • ASTL -0.07
  • Stochastic Oscillator
  • TRVI 89.91
  • ASTL 28.07

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

Share on Social Networks: